Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.
IBB vs PULS: how they differ
IBB and PULS hold 0% of their weight in the same names, and IBB returned more over the year.
iShares Biotechnology ETF and PGIM Ultra Short Bond ETF.
What they hold in common
By the books each fund has filed, IBB and PULS hold 0% of their money in the same securities at the same weight.
| Only in IBB | Only in PULS |
|---|---|
| Vertex Pharmaceuticals, Inc. 8.09% | PGIM ETF Trust 2.38% |
| Amgen, Inc. 7.84% | GLENCORE FUNDING LLC 0.98% |
| Gilead Sciences, Inc. 6.85% | Alexandria Real Estate Equities, Inc. 0.87% |
| Regeneron Pharmaceuticals, Inc. 4.91% | ABN AMRO BANK NV 0.75% |
| Argenx SE 3.76% | BX TRUST 2022-LBA6 0.68% |
| Alnylam Pharmaceuticals, Inc. 3.12% | FEDERATION DES CAISSES DESJARDINS DU QUE 0.67% |
| Natera, Inc. 2.89% | BX TRUST 2018-BILT 0.56% |
| Revolution Medicines, Inc. 2.78% | BROADCOM INC 0.56% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026 and May 29, 2026.
| IBB iShares Biotechnology ETF | PULS PGIM Ultra Short Bond ETF | |
|---|---|---|
| Where it sits | Core index fund | Core index fund |
| Issuer | iShares | PGIM |
| What it is | Biotechnology | PGIM Ultra Short Bond |
| Total return, 1 year | +41.5% | +4.2% |
| S&P 500 over the same days | +17.5% | +17.5% |
| Gap to the S&P 500 | +24.0 pts | −13.3 pts |
| Expense ratio | 0.44% | 0.15% |
| Holdings | 248 | 553 |
IBB in plain words
IBB is an index equity fund tracking the Biotechnology. Over the year to Sep 11, 2026 it returned +41.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Jun 30, 2026, 36% of the fund by weight is stocks the S&P 500 also holds, across 248 positions, with the top ten at 44.8%. It sat 6.5% below its high of Aug 19, 2026 on Sep 11, 2026.
PULS in plain words
PULS is a cash and treasury bills tracking the PGIM Ultra Short Bond. Over the year to Sep 11, 2026 it returned +4.2% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.15% a year.
Questions people ask
- Which returned more over the last year, IBB or PULS?
- In the year to Sep 12, 2026, with distributions reinvested, IBB returned +41.5% and PULS returned +4.2%, so IBB returned more. One year is one year; the longer windows are in the table.
- Which is cheaper, IBB or PULS?
- IBB charges 0.44% a year and PULS charges 0.15%, so PULS is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where to next
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, IBB against PULS, data as of Sep 12, 2026. https://etfiq.com/compare/any/IBB-PULS Free to use with attribution; the underlying files are at Open data.
A comparison is not a recommendation. Standards and sources